Published in

Elsevier, Clinical Breast Cancer, 2(19), p. 137-145.e4, 2019

DOI: 10.1016/j.clbc.2018.11.009

Links

Tools

Export citation

Search in Google Scholar

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study

Journal article published in 2019 by Sara Gagno ORCID, Mario Rosario D’Andrea, Mauro Mansutti, Chiara Zanusso, Fabio Puglisi ORCID, Eva Dreussi, Marcella Montico, Paola Biason ORCID, Erika Cecchin, Donatella Iacono, Stefania Russo, Marika Cinausero, Silvana Saracchini, Giampietro Gasparini, Donata Sartori and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO